Cardiac human bitter taste receptors contain naturally occurring variants that alter function.

Cardiovascular Cell signaling Genetic polymorphism Physiology Taste receptor subtype 2

Journal

Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032

Informations de publication

Date de publication:
19 Nov 2023
Historique:
received: 13 07 2023
revised: 26 10 2023
accepted: 16 11 2023
pubmed: 22 11 2023
medline: 22 11 2023
entrez: 21 11 2023
Statut: aheadofprint

Résumé

Bitter taste receptors (T2R) are a subfamily of G protein-coupled receptors that enable humans to detect aversive and toxic substances. The ability to discern bitter compounds varies between individuals and is attributed mainly to naturally occurring T2R polymorphisms. T2Rs are also expressed in numerous non-gustatory tissues, including the heart, indicating potential contributions to cardiovascular physiology. In this study. T2Rs that have previously been identified in human cardiac tissues (T2Rs - 10, 14, 30, 31, 46 and 50) and their naturally occurring polymorphisms were functionally characterised. The ligand-dependent signaling responses of some T2R variants were completely abolished (T2R30 Leu

Identifiants

pubmed: 37989413
pii: S0006-2952(23)00525-7
doi: 10.1016/j.bcp.2023.115932
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115932

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Conor J Bloxham (CJ)

School of Biomedical Sciences, Faculty of Medicine, University of Queensland, QLD, Australia; Regenerative Medicine in Cardiovascular Diseases, First Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Germany.

Katina D Hulme (KD)

School of Chemistry and Molecular Biosciences, Faculty of Science, University of Queensland, QLD, Australia; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.

Fabrizio Fierro (F)

Institute of Biochemistry, Food Science and Nutrition, The Hebrew University of Jerusalem, Israel.

Christian Fercher (C)

Australian Institute for Bioengineering and Nanotechnology, University of Queensland, QLD, Australia.

Cassandra L Pegg (CL)

School of Chemistry and Molecular Biosciences, Faculty of Science, University of Queensland, QLD, Australia.

Shannon L O'Brien (SL)

Institute of Metabolism and Systems Research, University of Birmingham, United Kingdom; Centre of Membrane Proteins and Receptors (COMPARE), Universities of Nottingham and Birmingham, Birmingham, United Kingdom.

Simon R Foster (SR)

School of Biomedical Sciences, Faculty of Medicine, University of Queensland, QLD, Australia; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.

Kirsty R Short (KR)

School of Chemistry and Molecular Biosciences, Faculty of Science, University of Queensland, QLD, Australia.

Sebastian G B Furness (SGB)

School of Biomedical Sciences, Faculty of Medicine, University of Queensland, QLD, Australia; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.

Melissa E Reichelt (ME)

School of Biomedical Sciences, Faculty of Medicine, University of Queensland, QLD, Australia.

Masha Y Niv (MY)

Institute of Biochemistry, Food Science and Nutrition, The Hebrew University of Jerusalem, Israel.

Walter G Thomas (WG)

School of Biomedical Sciences, Faculty of Medicine, University of Queensland, QLD, Australia. Electronic address: w.thomas@uq.edu.au.

Classifications MeSH